Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stem / Stromal Cells for Osteoarthritis

NCT04453111 is registered in ClinicalTrials.gov with Institute of Cell Therapy as lead sponsor.

NCT NCT04453111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04453111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stem / Stromal Cells for Osteoarthritis
Lead sponsor
Institute of Cell Therapy
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 2, 2020
Completion date
October 31, 2021
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis